Catalyst Wire Dossier Catalyst Wire Dossier

DPX-Survivac Vaccine

· Immunovaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DPX-Survivac Vaccine, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]

See pricing